Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling

Fig. 3

SEMA4D affects chemotherapy sensitivity of daunorubicin and mediates PI3K/Akt phosphorylation in AML cells. A IC50 curves of Daunorubicin in U937 and Molm-13 cells transfected with lentivirus targeting SEMA4D or control. Transduced AML cells were treated with daunorubicin for 48 h and then measured by CCK-8 analysis. B Cell apoptosis rate of U937 and Molm-13 cells transfected with lentivirus targeting SEMA4D or control after Daunorubicin drug treatment was detected by flow cytometry using Annexin V-APC /PI staining. C Western blotting analysis was used to determine the expression of p-PI3K, PI3K, p-Akt, Akt in U937 and Molm-13 cells transfected with lentivirus targeting SEMA4D or control. Results of densitometry analysis of relative expression levels after normalization to loading control β-actin are presented. Data with statistical significance are as indicated, *P < 0.05, **P < 0.01, ***P < 0.001, ns not significant

Back to article page